Navigation Links
Fleet Phospho-Soda Recalled
Date:12/15/2008

NEW YORK, Dec. 15 /PRNewswire/ -- An over the counter drug used to cleanse the bowel before colonoscopy was recalled last week because of serious side effects including destruction of the kidneys. The product, Fleet Phospho-Soda, made by C.B. Fleet, Co., of Virginia, is involved in product liability lawsuits around the country. The law firm of Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, has filed suit on behalf of a number of patients with kidney damage who used Fleet's product.

Fleet's recall followed the release of a Safety Alert by the Food and Drug Administration on Thursday warning consumers not to use over-the-counter laxatives, including Fleet's, in preparation for a colonoscopy due to the risk of kidney damage. The FDA will also now require prescription bowel cleansers, such as Visicol, to carry a black box warning about the risk of kidney damage. Since Fleet's is not a prescription product, it could not comply with the new FDA requirements, thus leading to the recall.

The lawsuits against Fleet allege that it improperly marketed Phospho-Soda at higher dosages than permitted by the FDA for over-the-counter oral laxatives containing sodium phosphate. "The FDA regulations are clear about the maximum daily dosage for these products, but Fleet continued for many years up until this recall to advise doctors and consumers to use twice the daily amount of its product that was permitted by the FDA," said Thomas P. Valet of the Rheingold, Valet law firm.

The safety of the higher dosages has never been demonstrated, according to Valet, who said that the higher dosage leads to deposits of calcium and phosphate in the kidneys, a condition known as nephrocalcinosis. In most cases, damage to the kidneys is permanent, requiring dialysis or even a transplant. The risk of kidney damage is increased in certain patients, according to Valet, including patients taking certain blood pressure medications or diuretics, and the risk of kidney damage increases with a patient's age. Valet said, however, that even those without a pre-existing risk factor can develop kidney failure after using Fleet's.

The link between kidney damage and Fleet's was first reported by a group of doctors in New York in 2003. Valet said that doctors from this group are working with his firm on behalf of injured patients and have been invaluable in helping prepare the cases against Fleet.

Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, is a New York based firm which handles mass tort litigation involving drugs and devices nationwide for the plaintiff's side. Partners in the firm have participated in the management of dozens of drug and medical device class actions and consolidated lawsuits around the country.

Contact: Thomas P. Valet, Esq. Or Paul D. Rheingold, Esq. (212)684-1880


'/>"/>
SOURCE Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Fleeting Facial Expressions Reveal Deep Secrets
2. Sikorsky Aircraft and PHI Celebrate Fleet Expansion and 20K Milestone at Heli-Expo
3. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
4. TriWest On Deck to Support Fleet Week San Diego
5. Jay C Stores Ask Customers to Check for Recalled Ground Beef
6. Study finds that recalled Aqua Dots did contain poisonous chemical
7. FDA Finds Contaminant in Baxters Recalled Heparin Products
8. Deli Chef Tri-Bean Salad Recalled From Some Kroger Stores
9. Common Infant Vaccine Recalled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... 2017 , ... Conventus, New Jersey’s premier professional liability insurer ... new educational series of webinars and podcasts to guide medical practices on understanding ... The first two episodes of the series, entitled “Pain Management and Opioids: New ...
(Date:7/27/2017)... Wayne, NJ (PRWEB) , ... July 27, 2017 ... ... C. Breiterman is now inviting new patients with sleep apnea in ... referral. Dental sleep medicine helps patients treat their sleep apnea with the use ...
(Date:7/27/2017)... , ... July 27, 2017 , ... For bicycling enthusiasts ... does challenge. The 24-hour race takes place against a backdrop of tree-lined hills at ... to run from July 28-30, Rad am Ring consists of some 73 curves, stretching ...
(Date:7/27/2017)... CA (PRWEB) , ... July 27, 2017 , ... ... the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution to its ... accelerated diagnostics and sleep care management. The speed and functionality of scoring in ...
(Date:7/27/2017)... ... July 27, 2017 , ... GAFFEY ... internal promotion of Elrene Clinkscales to Vice President of Revenue Cycle Business Services ... reporting to Derek Morkel, chief executive officer (CEO). , Elrene has been with ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Inc. ("Hill-Rom") (NYSE: HRC), today announced financial results for ... updated its financial outlook for fiscal 2017. ... quarter, Hill-Rom reported earnings of $0.09 per diluted share ... period. These results reflect after-tax special items, including a ... the non-cash write-down of assets associated with the planned ...
(Date:7/28/2017)... FLINT, Mich. , July 28, 2017 EnvoyHealth, ... (CMT) to pilot a program for CleverCap LITE, a ... CMT strives to deliver innovative health technology solutions ... adherence. CleverCap LITE ... The compact, high-tech bottle cover: ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
Breaking Medicine Technology: